Psychiatric Disorders Clinical Trial
Official title:
Can Brief Mindfulness-oriented Interventions Improve Psychiatric Symptoms and Shorten Psychiatric Hospitalizations? A Randomized Controlled Trial
Verified date | September 2020 |
Source | Lady Davis Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Mindfulness-based interventions have gained increasing popularity in recent years as
effective treatment for mental illness. Mindfulness is defined as paying attention in a
particular way: on purpose, in the present moment, and non-judgmentally: "Being", rather than
"Doing". Such mental states can improve emotional regulation through frontal cortex
inhibition of otherwise dysregulated subcortical emotion-related circuits. Formal mindfulness
approaches such as mindfulness-based cognitive therapy (MBCT) and mindfulness-based stress
reduction, have been highly effective in a broad range of psychiatric disorders.
Mindfulness-oriented interventions, are potentially useful in acute psychiatric
hospitalizations, since they can be delivered as group therapies and are be both
cost-effective and scalable. However, such interventions have rarely been provided to
patients during psychiatric hospitalizations, where patients are treated for a variety of
psychiatric diagnoses, and may have unpredictable lengths of stay. Additionally, there had
been concerns that longer traditional mindfulness based interventions (e.g. 30 minute silent
meditation) may exacerbate acute psychosis. However, strong evidence suggests that patients
with psychotic symptoms appear to be largely unaffected by shorter interventions. Similarly,
MBCT have been helpful to treat other major reasons for hospitalization such as: bipolar
disorder, severe anxiety, substance use disorders, and major depressive disorder.
Few studies have examined mindfulness-oriented treatments in inpatient settings, including
two small studies involving mindfulness groups on an acute psychiatric inpatient ward (n<10)
. Another study (n=23) offered inpatients with a diagnosis of major depressive disorder
mindfulness-based activities. All studies concluded that mindfulness-oriented approaches in
inpatient settings were feasible, although these needed to be brief interventions, given the
risks and lack of efficacy of longer MBI (e.g. 40-minute silent meditation) in severe mental
illness.
A cross-sectional study conducted by our team (n=40) demonstrated that brief group
mindfulness-oriented lasting 10 minutes were very well tolerated by 92.5% of psychiatric
inpatients. The remaining 7.5% of patients left the session before 10-minutes, but had no
symptomatic exacerbations or adverse effects. Moreover, the 50% of patients self- reported
improvements in general well-being and mood after a single 10-minute session. Having been
recently admitted to the psychiatric inpatient or having a diagnosis of acute psychosis (75%
of inpatients) did not affect patients' capacity to tolerate and benefit from the
intervention. In this inpatient psychiatric population, we found that mindfulness-oriented
interventions that were brief and involved physical movement (e.g. seated Tai Chi) were
better enjoyed compared to other interventions.
Despite the growing literature in this field, data is needed on the effectiveness and health
service implications of brief group mindfulness-oriented interventions in inpatient
psychiatry settings. Outcome studies conducted so far cannot be interpreted reliably due to
methodological flaws, including inadequate control groups, very small sample sizes (often
n<10), and lack of randomization. In Canada, the direct cost of treatment for mental illness
is estimated as 42.3 billion. Much of these costs are driven by psychiatric admissions. Thus,
if brief mindfulness-oriented interventions are effective at lowering psychiatric symptom
severity and shortening psychiatric hospitalizations, this could lead to significant
cost-savings.
Status | Completed |
Enrollment | 20 |
Est. completion date | February 1, 2020 |
Est. primary completion date | February 1, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Age 18 years and above 2. Admitted to the Open Unit of Jewish General Hospital Psychiatric Inpatient Unit Exclusion Criteria: 1. Acute high risk to self and others - defined by being hospitalized in the confined (locked) unit (High Care or UTT at JGH). 2. Have been diagnosed by their psychiatrist with a diagnosis of moderate-to-severe dementia that would interfere with their ability to complete self-reported questionnaires. |
Country | Name | City | State |
---|---|---|---|
Canada | Jewish General Hospital | Montréal | Quebec |
Lead Sponsor | Collaborator |
---|---|
Lady Davis Institute |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Insomnia with Athens scale | At admission to the psychiatry unit and at 1-week follow-up | ||
Other | Quality of life assessed with Euro-QOL scale | At admission to the psychiatry unit and at 1-week follow-up | ||
Other | Psychotropic medication and "as needed" PRN medication use | At admission to the psychiatry unit and at 1-week follow-up | ||
Other | Likert Scale | The patient's satisfaction will be assessed with a 10 point Likerts scale | At 1-week follow-up | |
Primary | Change in Brief Psychiatric Rating Scale score | 1-week follow-up | ||
Secondary | Inpatient Psychiatric length of stay (days) | Within 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00166764 -
A Study on Evaluation of Mental Health Index of Patients With Psychiatric Disorders
|
N/A | |
Recruiting |
NCT06062953 -
Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia
|
Phase 2/Phase 3 | |
Recruiting |
NCT05548946 -
A Dimensional Model for Personality Disorders in Later Life
|
N/A | |
Completed |
NCT03313154 -
Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-related
|
||
Completed |
NCT00783783 -
CYP2D6 Pharmacogenetics in Risperidone-Treated Children
|
N/A | |
Completed |
NCT01989728 -
Prevalence and Effect of Detecting Common Mental Disorders in Long-term Sickness Absence
|
N/A | |
Completed |
NCT03125083 -
Role of Inflammation in Psychiatric Disorders in Patients With Cutaneous Lupus
|
N/A | |
Recruiting |
NCT01066299 -
Influence of Oxytocin on the Startle Reflex and on Its Modulation
|
N/A | |
Recruiting |
NCT05784818 -
Up To Me: Erasing the Stigma of Mental Illness on College Campuses
|
N/A | |
Completed |
NCT01786733 -
Behavioral Activation - From Inpatient to Outpatient Services
|
N/A | |
Withdrawn |
NCT03907124 -
Clinical Utility of Pharmacogenomics of Psychotropic Medications
|
Phase 4 | |
Withdrawn |
NCT03809897 -
Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders
|
Phase 4 | |
Not yet recruiting |
NCT02857322 -
Effectiveness Accompaniment Perioperative Patients With Psychiatric Illness on the Lives Perioperative
|
N/A | |
Terminated |
NCT02665988 -
Adjunctive Transcranial Direct Current Stimulation
|
N/A | |
Completed |
NCT01289080 -
Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects
|
Phase 1 | |
Completed |
NCT01823250 -
Culturally Informed Family Based Treatment of Adolescents: A Randomized Trial
|
Phase 2 | |
Active, not recruiting |
NCT00982943 -
The Epidemiological Study on Psychiatric Disorders and Psychotropic Drugs
|
N/A | |
Completed |
NCT00184340 -
Secured Internet-mediated Psychotherapy With Psychiatry Patients
|
N/A | |
Completed |
NCT00184327 -
Changes Following Inpatient Child-oriented Family Treatment
|
Phase 1 | |
Recruiting |
NCT04381845 -
Immunity and Infections in the Psychiatric Population
|
N/A |